The basic principles of successful therapeutic cancer vaccine administration include delivering a large number of high-quality antigens to DCs, optimal activation of DCs, induction of robust and sustained CD4+ T cell and cytotoxic T lymphocyte(CTL) responses, infiltration of the tumor microenvironment (TME), and persistence and maintenance of the immune response. The gene discussed is CD4; the disease is neoplasm.